Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Integrative transcriptomics and cell systems analyses reveal protective pathways controlled by Igfbp‐3 in anthracycline‐induced cardiotoxicity

The FASEB Journal(2023)10.1096/fj.202201885rrSource: DataRank Database

Integrative transcriptomics and cell systems analyses reveal protective pathways controlled by Igfbp‐3 in anthracycline‐induced cardiotoxicity is a research paper published in The FASEB Journal (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.58)OA: bronzeTopics (70)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Douglas J. Chapski ORCID,Jeremy Jong,Jerome Awada,Yijie Wang ORCID,Dennis J. Slamon ORCID

Live enrichment

PubMed:37219486 OpenAlex:https://openalex.org/W4377564259

U.S. Department of Veterans Affairs

Grant: BX004558

National Institutes of Health

Grant: 3UL1TR001881-01S2

UCLA Clinical Translational Science Institute

National Institutes of Health

Grant: 1R56HL158569-01A1

Dissecting mechanisms of anthracycline-induced cardiotoxicity

FWCI

1.58

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

bronzeLicense: Wiley Online Library User Agreement

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1096/fj.202201885RR

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1096/fj.202201885RR

publisherhttps://faseb.onlinelibrary.wiley.com/doi/pdf/10.1096/fj.202201885RR

journalhttps://doi.org/10.1096/fj.202201885rr

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37219486

Fields of Study

Chemotherapy-induced cardiotoxicity and mitigationMetabolism, Diabetes, and CancerNeuroblastoma Research and Treatments03 medical and health sciences0303 health sciences

MeSH Terms

AnimalsAntibiotics, AntineoplasticDoxorubicinHumansDNA AdductsAnthracyclinesMyocytes, CardiacRatsTranscriptomeCardiotoxicity

Keywords

CardiotoxicityDoxorubicinDNA damageAnthracyclineContractilityCell biologyMyocyteBiologyCancer researchCell growthTranscriptomeHeart failurePharmacologyChemistryDNAInternal medicineEndocrinologyMedicineBiochemistryGene expressionCancerGeneticsChemotherapyGene570Biochemistry & Molecular BiologyiPSC-CMPhysiologyMedical Physiology610cardiomyocytesCardiovasculartranscriptomicsDNA AdductsAntibiotics2.1 Biological and endogenous factorsHumansAnimalsAnthracyclinesMyocytes, CardiacMyocytesAntibiotics, AntineoplasticBiomedical and Clinical SciencesStem Cell Research - Induced Pluripotent Stem Cell - HumanStem Cell Research - Induced Pluripotent Stem CellBiological SciencesStem Cell ResearchAntineoplasticRatsHeart DiseaseNRVMIgfbp-3cardioprotectionBiochemistry and cell biologyCardiac

Sustainable Development Goals

SDG 0: Good health and well-being